Press Release

Venom Based Drugs Market to be dominated by Rising Research and Development activities through 2027

Growing awareness and increasing occurrences of diseases to drive the venom-based drugs market in the forecast period, 2023-2027.

According to TechSci Research report, “Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027, the global venom based drugs market is anticipated to grow at a significant rate in the forecast period, 2023-2027. The increase in prevalence of various kinds of diseases, and extensive research and development are the primary factors driving the demand for the global venom based drugs market. Growing technological advancements, rising livestock population base, large number of clinical trials, and rising investments on R&D activities are expected to influence the market demand. Also, the ease in approval of new venom-based drugs is a key factor for increasing the growth of the venom based drugs market, globally.

However, the drug development from animal venom is an expensive, dangerous, and often unprofitable venture which may likely hamper the growth of the global venom based drugs market.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Venom Based Drugs Market"

The global venom-based drugs market is segmented into animal type, source, therapeutic area, and company.

Based on animal type, the market is divided into snake, spider, bee, and others. The snake segment is expected to witness the significant growth in the upcoming years. This is ascribed to the large abundance of snake species, and it has potential therapeutic effects.  

Based on source, the market is divided into whole venom, synthetic, recombinant, and others. The whole venom sub-segment is expected to hold the considerable market share.

Based on therapeutic area, the market is segmented into hypertension, cardiovascular diseases, neurological disorders, pain management & arthritis, and others. The cardiovascular diseases segment is expected to witness largest market share. This is attributed to the rise in number of patients suffering from cardiovascular diseases.

Major operating companies operating in global venom based drugs market are:

  • AstraZeneca Plc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Pentapharm Limited
  • Medicure Inc
  • Millennium Pharmaceuticals, Inc.
  • Bausch Health Companies, Inc.
  • Novartis AG
  • Elan Pharmaceuticals, Inc.
  • Beijing Tobishi Pharmaceutical Co., Ltd.


Download Free Sample Report

Customers can also request for 10% free customization on this report.

“North America region dominates the market in 2021 and is expected to maintain its dominance in the coming years due to increased research and innovations in venom based drugs. The huge investments by government and non-government organization on healthcare sector and rise in skilled expertise are propelling the market growth. Also, rise in number of venomous animals in the region are expected to propel the global Venom Based Drugs market growth till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region”, has evaluated the future growth potential of global venom based drugs market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global venom based drugs market.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com

Relevant News